Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Tetanus, diphtheria, and acellular pertussis vaccine
BIOLOGICAL
2 trials
Sponsors
Pfizer
, Celgene
Conditions
Group B Streptococcus Infections
Multiple Sclerosis
Multiple Sclerosis, Relapsing-Remitting
Phase 2
Trial to Evaluate the Safety, Tolerability, and Immunogenicity of A Multivalent Group B Streptococcus Vaccine When Administered Concomitantly With Tdap in Healthy Nonpregnant Women
Completed
NCT04766086
Pfizer
Group B Streptococcus Infections
Start: 2022-08-12
End: 2023-04-27
Updated: 2024-05-24
Phase 3
Safety Study to Evaluate Immune Response of Vaccines in Participants With Relapsing Forms of Multiple Sclerosis Who Receive Ozanimod Compared to Non-Pegylated Interferon (IFN)-β or No Disease Modifying Therapy
Completed
NCT05028634
Celgene
Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting
Start: 2021-11-11
End: 2023-11-15
Updated: 2025-02-11
Related Papers
A Phase 2b Trial Evaluating the Safety, Tolerability, and Immunogenicity of a 6-Valent Group B <i>Streptococcus</i> Vaccine Administered Concomitantly With Tetanus, Diphtheria, and Acellular Pertussis Vaccine in Healthy Nonpregnant Female Individuals
The Journal of Infectious Diseases
2025-02-26
7 citations